Table 2.

Plasmids used in this study

Name Genotype Reference/source 
pADH181 pA-TEV-ctrsa4 Δ1–29 , LEU2, AmpR, PADH1 pA-TEV-ctrsa4 30–517aa, Chaetomium thermophilum Rsa4 This study 
pASΔΔ NSA2 2µ, TRP1, PADH1 Gal4-DNA BD-NSA2 This study 
pASΔΔ nsa2 C (ΔN4) See above, pASΔΔ Nsa2 141–261 aa This study 
pASΔΔ nsa2 N (ΔC4) See above, pASΔΔ Nsa2 1–144 aa This study 
pASΔΔ nsa2 ΔN1 See above, pASΔΔ Nsa2 77–261 aa This study 
pASΔΔ nsa2 ΔN2 See above, pASΔΔ Nsa2 35–261 aa This study 
pEcOmeTyr/ectRNACUA CEN, TRP1, expression of amber suppressor ectRNACUA and aminoacyl ectRNA-synthetase Chin et al., 2003  
pET Duet1 rsa4 Δ136 AmpR, PT7 rsa4 ΔN 136 aa This study 
pET24d HIS6-TEV-ctnsa2 1–84 KanR, PT7 HIS6-TEV-ctnsa2 1–84 aa Chaetomium thermophilum Nsa2 This study 
pET24d HIS6-TEV-ctnsa2 168–261 KanR, PT7 HIS6-TEV-ctnsa2 168–261 aa Chaetomium thermophilum Nsa2 This study 
pET24d HIS6-TEV-RSA4 KanR, PT7 HIS6-TEV-RSA4 This study 
pET24d HIS6-TEV-RSA4 KanR, PT7 HIS6-TEV-RSA4 This study 
pET24d HIS6-TEV-rsa4 b1* KanR, PT7 HIS6-TEV-rsa4 T175R,T177R This study 
pET24d HIS6-TEV-rsa4 b8* KanR, PT7 HIS6-TEV-rsa4 K130E,R134E This study 
pET24d HIS6-TEV-rsa4 Y448E KanR, PT7 HIS6-TEV-rsa4 Y448E This study 
pETM43 MBP KanR, empty vector, PT7, MBP control EMBL Core facility 
pETM43 MBP-PRE-NSA2 KanR, PT7 MBP-PRE-NSA2 This study 
pETMBPxray_V43 KanR, PT7, MBP (optimized for carrier-driven crystallization: D82A, K83A, K239A, E359A, K362A, D363A)-linker (AAAA) NcoI This study 
pETMBPxray_V43 MBP-nsa2 81–101 See above, Nsa2 peptide: 81–101 aa This study 
pETMBPxray_V43 MBP-nsa2 84–96 See above, Nsa2 peptide: 84–96 aa This study 
pG4ADHAN RSA4 CEN, LEU2, PADH1 GAL4-AD-RSA4 1–515 aa This study 
pGADT7 rsa4 MIDO , LEU2, PADH1 GAL4-AD-rsa4 1–154 aa Ulbrich et al., 2009  
pHAC111 NOG1 LEU2, NOG1-HA3 Honma et al., 2006  
pHAC111 nog1-11 LEU2, nog1-11-HA3 Honma et al., 2006  
pnatNT2 PRSA4 NTAP-FLAG CEN, AmpR, PTEF1 natNT2 TADH1, PRSA4 2× pA-TEV-CBP-FLAG, integration cassette This study 
pRS314 NSA2 CEN, TRP1, AmpR, PNSA2 NSA2 This study 
pRS314 nsa2-1 CEN, TRP1, AmpR, PNSA2 nsa2-1, point mutation in STOP leads to elongation of Nsa2p by 17 aa: RAKKCSVFFFFYLDGSN* This study 
pRS314 nsa2-3 CEN, TRP1, AmpR, PNSA2 nsa2 N203K This study 
pRS314 nsa2-9 CEN, TRP1, AmpR, PNSA2 nsa2 S177R,H186P This study 
pRS314 RSA4 CEN, TRP1, AmpR, PRSA4 RSA4 Ulbrich et al., 2009  
pRS314 rsa4-1 CEN, TRP1, AmpR, PRSA4 rsa4-1 Ulbrich et al., 2009  
pRS315 IPI3 CEN, LEU2, AmpR, PIPI3 IPI3 This study 
pRS315 ipi3-2 CEN, LEU2, AmpR, PIPI3 ipi3-2 This study 
pRS315 NSA2 CEN, LEU2, AmpR, PNSA2 NSA2 This study 
pRS315 nsa2 Y90A CEN, LEU2, AmpR, PNSA2 nsa2 Y90A This study 
pRS315 nsa2 Y90F CEN, LEU2, AmpR, PNSA2 nsa2 Y90F This study 
pRS315 rix1-1 CEN, LEU2, AmpR, PRIX1 rix1-1 Baßler et al., 2001  
pRS315 RSA4 CEN, LEU2, AmpR, PRSA4 RSA4 Ulbrich et al., 2009  
pRS315 rsa4-1 CEN, LEU2, AmpR, PRSA4 rsa4-1 Ulbrich et al., 2009  
pRSF Duet1 GST-TEV-NSA2 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-NSA2 + PT7 HIS6-TEV-RSA4 This study 
pRSF Duet1 GST-TEV-NSA2 Δ85–98 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-nsa2 Δ 85–98 aa + PT7 HIS6-TEV-RSA4 This study 
pRSF Duet1 GST-TEV-NSA2 Δ86–90 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-nsa2 Δ 86–90 aa + PT7 HIS6-TEV-RSA4 This study 
pT7 HIS6-rsa4 ΔN KanR, PT7 HIS6-RSA4 ΔN 112–516 aa This study 
pT7 HIS6-TEV-rsa4 ΔN26 KanR, PT7 HIS6-TEV-rsa4 27–515 aa This study 
pTD1-1 , LEU2, GAL4 AD-SV40 large T-antigen (84-708 aa), pACT2 Takara Bio Inc. 
pUN100 RIX1 CEN, LEU2, AmpR, PRIX1 RIX1 Baßler et al., 2001  
pVA3-1 , TRP1, GAL4 DNA BD-murine p53 (72–390 aa), pGBT9 Takara Bio Inc. 
YCplac111 NSA2-FTpA CEN, LEU2, AmpR, PNSA2 NSA2-LINKER-FLAG-TEV-pA, Linker:ASSYTAPQPGLGGS This study 
YCplac111 nsa2-FTpA Δ85–98 See above, PNSA2 nsa2-L-FTpA, Δ 85–98 aa This study 
YCplac111 nsa2-FTpA Δ86–90 See above, PNSA2 nsa2-L-FTpA, Δ 86–90 aa This study 
YCplac111 PGAL NSA2-FTpA CEN, LEU2, AmpR, PGAL1-10 NSA2-LINKER-FLAG-TEV–pA,Linker:ASSYTAPQPGLGGS This study 
YCplac111 PGAL nsa2-FTpA Δ85–98 See above, PGAL1-10 nsa2-L-FTpA, Δ 85–98 aa This study 
YCplac111 PGAL nsa2-FTpA Δ86–90 See above, PGAL1-10 nsa2-L-FTpA, Δ 86–90 aa This study 
YCplac111 RPL5 CEN, LEU2, AmpR, PRpl5 RPL5 This study 
YCplac111 rpl5 Δloop2 See above, Δ 122–138 aa This study 
YCplac111 rpl5 Δloop2+3 See above, Δ 122–138 aa, Δ185–198>R aa This study 
YCplac111 rpl5 Δloop3 See above, Δ 185–198>R aa This study 
YCplac111 RPL5-FTpA CEN,LEU2,AmpR,PRPL5 RPL5-5xGA-FTpA This study 
YCplac111 rpl5-FTpA Δloop2 See above, Δ 122–138 aa This study 
YCplac111 rpl5-FTpA Δloop2+3 See above, Δ 122–138 aa, Δ 185–198>R aa This study 
YCplac111 rpl5-FTpA Δloop3 See above, Δ 185–198>R aa This study 
YCplac111 RPL5-GFP CEN, LEU2, AmpR, PRPL5 RPL5-GFP This study 
YCplac111 rpl5-GFP Δloop2+3 See above, Δ 122–138 aa, Δ 185–198>R aa This study 
YCplac111 TAP-FLAG-rsa4 b1* CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 K130E,R134E This study 
YCplac111 TAP-FLAG-rsa4 b8* CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 T175R,T177R This study 
YCplac111 TAP-FLAG-rsa4 Y448E CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 Y448E This study 
YCplac22 NSA2-FTpA CEN, TRP1, AmpR, PNSA2 NSA2-LINKER-FLAG-TEV-pA, Linker:ASSYTAPQPGLGGS This study 
YCplac22 nsa2-FTpA Y90A See above, PNSA2 nsa2-LINKER-FLAG-TEV-pA, nsa2 Y90A, Linker:ASSYTAPQPGLGGS This study 
YEplac112 PGAL1-10 NSA2 , TRP1, AmpR, PGAL1-10 NSA2 This study 
YEplac112 PGAL1-10 nsa2 Y90A See above, PGAL1-10 nsa2 Y90A This study 
YEplac112 PGAL1-10 RSA4 See above, PGAL1-10 RSA4 This study 
YEplac112 PGAL1-10 rsa4 b1* See above, PGAL1-10 rsa4 K130E,R134E This study 
YEplac112 PGAL1-10 rsa4 b8* See above, PGAL1-10 rsa4 T175R,T177R This study 
YEplac112 PGAL1-10 rsa4 Y448E See above, PGAL1-10 rsa4 Y448E This study 
YEplac181 PGAL1-10 NSA2 PGAL1-10-tc-apt-2×HA-TAG-RPL25-FTpA , LEU2, AmpR, PGAL1-10 NSA2 TADH1, PGAL1-10 tetracycline-aptamer-2×HA-amber-RPL25-FLAG-TEV-pA TADH1 This study 
YEplac181 PGAL1-10 nsa2 Y90A PGAL1-10-tc-apt-2×HA-TAG-RPL25-FTpA , LEU2, AmpR, PGAL1-10 nsa2 Y90A TADH1 PGAL1-10 tetracycline-aptamer-2×HA-amber-RPL25-FLAG-TEV-pA TADH1 This study 
Name Genotype Reference/source 
pADH181 pA-TEV-ctrsa4 Δ1–29 , LEU2, AmpR, PADH1 pA-TEV-ctrsa4 30–517aa, Chaetomium thermophilum Rsa4 This study 
pASΔΔ NSA2 2µ, TRP1, PADH1 Gal4-DNA BD-NSA2 This study 
pASΔΔ nsa2 C (ΔN4) See above, pASΔΔ Nsa2 141–261 aa This study 
pASΔΔ nsa2 N (ΔC4) See above, pASΔΔ Nsa2 1–144 aa This study 
pASΔΔ nsa2 ΔN1 See above, pASΔΔ Nsa2 77–261 aa This study 
pASΔΔ nsa2 ΔN2 See above, pASΔΔ Nsa2 35–261 aa This study 
pEcOmeTyr/ectRNACUA CEN, TRP1, expression of amber suppressor ectRNACUA and aminoacyl ectRNA-synthetase Chin et al., 2003  
pET Duet1 rsa4 Δ136 AmpR, PT7 rsa4 ΔN 136 aa This study 
pET24d HIS6-TEV-ctnsa2 1–84 KanR, PT7 HIS6-TEV-ctnsa2 1–84 aa Chaetomium thermophilum Nsa2 This study 
pET24d HIS6-TEV-ctnsa2 168–261 KanR, PT7 HIS6-TEV-ctnsa2 168–261 aa Chaetomium thermophilum Nsa2 This study 
pET24d HIS6-TEV-RSA4 KanR, PT7 HIS6-TEV-RSA4 This study 
pET24d HIS6-TEV-RSA4 KanR, PT7 HIS6-TEV-RSA4 This study 
pET24d HIS6-TEV-rsa4 b1* KanR, PT7 HIS6-TEV-rsa4 T175R,T177R This study 
pET24d HIS6-TEV-rsa4 b8* KanR, PT7 HIS6-TEV-rsa4 K130E,R134E This study 
pET24d HIS6-TEV-rsa4 Y448E KanR, PT7 HIS6-TEV-rsa4 Y448E This study 
pETM43 MBP KanR, empty vector, PT7, MBP control EMBL Core facility 
pETM43 MBP-PRE-NSA2 KanR, PT7 MBP-PRE-NSA2 This study 
pETMBPxray_V43 KanR, PT7, MBP (optimized for carrier-driven crystallization: D82A, K83A, K239A, E359A, K362A, D363A)-linker (AAAA) NcoI This study 
pETMBPxray_V43 MBP-nsa2 81–101 See above, Nsa2 peptide: 81–101 aa This study 
pETMBPxray_V43 MBP-nsa2 84–96 See above, Nsa2 peptide: 84–96 aa This study 
pG4ADHAN RSA4 CEN, LEU2, PADH1 GAL4-AD-RSA4 1–515 aa This study 
pGADT7 rsa4 MIDO , LEU2, PADH1 GAL4-AD-rsa4 1–154 aa Ulbrich et al., 2009  
pHAC111 NOG1 LEU2, NOG1-HA3 Honma et al., 2006  
pHAC111 nog1-11 LEU2, nog1-11-HA3 Honma et al., 2006  
pnatNT2 PRSA4 NTAP-FLAG CEN, AmpR, PTEF1 natNT2 TADH1, PRSA4 2× pA-TEV-CBP-FLAG, integration cassette This study 
pRS314 NSA2 CEN, TRP1, AmpR, PNSA2 NSA2 This study 
pRS314 nsa2-1 CEN, TRP1, AmpR, PNSA2 nsa2-1, point mutation in STOP leads to elongation of Nsa2p by 17 aa: RAKKCSVFFFFYLDGSN* This study 
pRS314 nsa2-3 CEN, TRP1, AmpR, PNSA2 nsa2 N203K This study 
pRS314 nsa2-9 CEN, TRP1, AmpR, PNSA2 nsa2 S177R,H186P This study 
pRS314 RSA4 CEN, TRP1, AmpR, PRSA4 RSA4 Ulbrich et al., 2009  
pRS314 rsa4-1 CEN, TRP1, AmpR, PRSA4 rsa4-1 Ulbrich et al., 2009  
pRS315 IPI3 CEN, LEU2, AmpR, PIPI3 IPI3 This study 
pRS315 ipi3-2 CEN, LEU2, AmpR, PIPI3 ipi3-2 This study 
pRS315 NSA2 CEN, LEU2, AmpR, PNSA2 NSA2 This study 
pRS315 nsa2 Y90A CEN, LEU2, AmpR, PNSA2 nsa2 Y90A This study 
pRS315 nsa2 Y90F CEN, LEU2, AmpR, PNSA2 nsa2 Y90F This study 
pRS315 rix1-1 CEN, LEU2, AmpR, PRIX1 rix1-1 Baßler et al., 2001  
pRS315 RSA4 CEN, LEU2, AmpR, PRSA4 RSA4 Ulbrich et al., 2009  
pRS315 rsa4-1 CEN, LEU2, AmpR, PRSA4 rsa4-1 Ulbrich et al., 2009  
pRSF Duet1 GST-TEV-NSA2 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-NSA2 + PT7 HIS6-TEV-RSA4 This study 
pRSF Duet1 GST-TEV-NSA2 Δ85–98 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-nsa2 Δ 85–98 aa + PT7 HIS6-TEV-RSA4 This study 
pRSF Duet1 GST-TEV-NSA2 Δ86–90 + HIS6-TEV-RSA4 KanR, PT7 GST-TEV-nsa2 Δ 86–90 aa + PT7 HIS6-TEV-RSA4 This study 
pT7 HIS6-rsa4 ΔN KanR, PT7 HIS6-RSA4 ΔN 112–516 aa This study 
pT7 HIS6-TEV-rsa4 ΔN26 KanR, PT7 HIS6-TEV-rsa4 27–515 aa This study 
pTD1-1 , LEU2, GAL4 AD-SV40 large T-antigen (84-708 aa), pACT2 Takara Bio Inc. 
pUN100 RIX1 CEN, LEU2, AmpR, PRIX1 RIX1 Baßler et al., 2001  
pVA3-1 , TRP1, GAL4 DNA BD-murine p53 (72–390 aa), pGBT9 Takara Bio Inc. 
YCplac111 NSA2-FTpA CEN, LEU2, AmpR, PNSA2 NSA2-LINKER-FLAG-TEV-pA, Linker:ASSYTAPQPGLGGS This study 
YCplac111 nsa2-FTpA Δ85–98 See above, PNSA2 nsa2-L-FTpA, Δ 85–98 aa This study 
YCplac111 nsa2-FTpA Δ86–90 See above, PNSA2 nsa2-L-FTpA, Δ 86–90 aa This study 
YCplac111 PGAL NSA2-FTpA CEN, LEU2, AmpR, PGAL1-10 NSA2-LINKER-FLAG-TEV–pA,Linker:ASSYTAPQPGLGGS This study 
YCplac111 PGAL nsa2-FTpA Δ85–98 See above, PGAL1-10 nsa2-L-FTpA, Δ 85–98 aa This study 
YCplac111 PGAL nsa2-FTpA Δ86–90 See above, PGAL1-10 nsa2-L-FTpA, Δ 86–90 aa This study 
YCplac111 RPL5 CEN, LEU2, AmpR, PRpl5 RPL5 This study 
YCplac111 rpl5 Δloop2 See above, Δ 122–138 aa This study 
YCplac111 rpl5 Δloop2+3 See above, Δ 122–138 aa, Δ185–198>R aa This study 
YCplac111 rpl5 Δloop3 See above, Δ 185–198>R aa This study 
YCplac111 RPL5-FTpA CEN,LEU2,AmpR,PRPL5 RPL5-5xGA-FTpA This study 
YCplac111 rpl5-FTpA Δloop2 See above, Δ 122–138 aa This study 
YCplac111 rpl5-FTpA Δloop2+3 See above, Δ 122–138 aa, Δ 185–198>R aa This study 
YCplac111 rpl5-FTpA Δloop3 See above, Δ 185–198>R aa This study 
YCplac111 RPL5-GFP CEN, LEU2, AmpR, PRPL5 RPL5-GFP This study 
YCplac111 rpl5-GFP Δloop2+3 See above, Δ 122–138 aa, Δ 185–198>R aa This study 
YCplac111 TAP-FLAG-rsa4 b1* CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 K130E,R134E This study 
YCplac111 TAP-FLAG-rsa4 b8* CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 T175R,T177R This study 
YCplac111 TAP-FLAG-rsa4 Y448E CEN, LEU2, AmpR, PRSA4 pA-CBP-2×FLAG-rsa4 Y448E This study 
YCplac22 NSA2-FTpA CEN, TRP1, AmpR, PNSA2 NSA2-LINKER-FLAG-TEV-pA, Linker:ASSYTAPQPGLGGS This study 
YCplac22 nsa2-FTpA Y90A See above, PNSA2 nsa2-LINKER-FLAG-TEV-pA, nsa2 Y90A, Linker:ASSYTAPQPGLGGS This study 
YEplac112 PGAL1-10 NSA2 , TRP1, AmpR, PGAL1-10 NSA2 This study 
YEplac112 PGAL1-10 nsa2 Y90A See above, PGAL1-10 nsa2 Y90A This study 
YEplac112 PGAL1-10 RSA4 See above, PGAL1-10 RSA4 This study 
YEplac112 PGAL1-10 rsa4 b1* See above, PGAL1-10 rsa4 K130E,R134E This study 
YEplac112 PGAL1-10 rsa4 b8* See above, PGAL1-10 rsa4 T175R,T177R This study 
YEplac112 PGAL1-10 rsa4 Y448E See above, PGAL1-10 rsa4 Y448E This study 
YEplac181 PGAL1-10 NSA2 PGAL1-10-tc-apt-2×HA-TAG-RPL25-FTpA , LEU2, AmpR, PGAL1-10 NSA2 TADH1, PGAL1-10 tetracycline-aptamer-2×HA-amber-RPL25-FLAG-TEV-pA TADH1 This study 
YEplac181 PGAL1-10 nsa2 Y90A PGAL1-10-tc-apt-2×HA-TAG-RPL25-FTpA , LEU2, AmpR, PGAL1-10 nsa2 Y90A TADH1 PGAL1-10 tetracycline-aptamer-2×HA-amber-RPL25-FLAG-TEV-pA TADH1 This study 

or Create an Account

Close Modal
Close Modal